H.C. Wainwright maintains Cara Therapeutic at 'buy' with a price target of $15.00

  • Investing.com
H.C. Wainwright maintains Cara Therapeutic at 'buy' with a price target of $15.00

An analyst from H.C. Wainwright maintained Cara Therapeutic (NASDAQ: CARA ) at 'buy' with a price target of $15.00 from a prior price target of $20.00.

Prior to this rating, Cara Therapeutic had 7 buy ratings, 0 hold ratings, and 1 sell ratings.

For consensus analyst estimates and price targets on Cara Therapeutic, click here. For more news on Cara Therapeutic, click here.

Cara Therapeutic's stock price closed at $4.15. They are down -6.32% in the last month and down -53.58% in the last 12 months.

According to Investing Pro, Cara Therapeutic's fair value is $4.24, an upside of 2.14%. Cara Therapeutic's fair value comes with a high degree of uncertainty, according to InvestingPro.

Check out Cara Therapeutic's recent earnings performance and financials here.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100